Public Health - Baby Food Testing and Labeling - Requirements
HB0196 expands Maryland’s baby food testing and disclosure requirements to cover a broader set of products and to strengthen consumer-facing labeling. The bill changes the definition of “baby food” for the testing law so that it includes infant formula and infant cereal, while also renaming “toxic heavy metal” as “toxic element.” It keeps the existing prohibition on selling baby food that exceeds FDA limits for arsenic, cadmium, lead, or mercury, and requires manufacturers to test representative samples of each production aggregate at least monthly using a proficient laboratory.
The bill also adds new public disclosure and labeling obligations. Beginning in 2026 for most baby food and in 2028 for infant cereal, manufacturers must post test-result information on their websites, include a QR code or other machine-readable code on product labels, and provide a statement directing consumers to testing information. For online sales, the product detail page must also direct consumers to the testing information page. The bill further requires manufacturers to retain certificates of analysis for five years beginning in 2028, and it allows consumers who believe a product exceeds FDA limits to report it to the Department.
HB0196 amends Section 21-330.4 of the Health-General Article, expanding the state’s baby food safety regime to include infant formula and infant cereal within the testing and labeling framework while preserving the FDA-based contamination limits. It creates new compliance duties for manufacturers, food processors, and food packers selling baby food in Maryland, including monthly testing, website disclosures, label statements, QR-code access to test results, online product-page notices, and record-retention requirements. It also authorizes continued sale of infant cereal manufactured before a specified date and updates terminology throughout the statute from “heavy metals” to “elements.”
The bill appears to have broad support, reflected in its introduction by a large bipartisan group of delegates and its favorable committee report with amendments. The available record shows House adoption and no recorded opposing votes or committee transcript objections. Overall, the sentiment suggests support for stronger transparency and safety standards for products marketed to infants and young children, with amendments likely used to refine implementation details rather than to challenge the bill’s core purpose.
The main points of potential contention are practical and definitional rather than ideological. One issue is the expanded scope of the law, especially the inclusion of infant formula and infant cereal, which could increase compliance burdens for manufacturers and raise questions about how the testing rules interact with federal regulation. Another likely area of debate is the timing of implementation and the staggered deadlines for labeling, online disclosures, and record retention, which may have been adjusted by amendment to give industry more time to comply. The bill also places responsibility on consumers to report suspected violations, which may be viewed as a useful enforcement tool or as an added burden depending on perspective.